Top

Published in:

01-02-2011 | Case Report

Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography

Authors: Isao Ishikawa, Kyoko Morita, Satoshi Hayama, Tetsuya Nakazawa, Ichiro Araki, Kotaro Higashi, Katsuhito Miyazawa, Koji Suzuki, Takayuki Nojima

Published in: Clinical and Experimental Nephrology | Issue 1/2011

Abstract

The preoperative assessment of renal cell carcinoma (RCC) complicated with acquired renal cystic disease in a 63-year-old male patient on long-term hemodialysis (30 years and 8 months) that was difficult because of no or poor contrast enhancement by dynamic CT scan is reported. Contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography (PET-CT) with 18F-fluorodeoxy glucose (FDG) in addition to dynamic CT were effective and useful for preoperative assessment of this patient. The pathological subtype of RCC in this patient was acquired cystic disease-associated RCC (ACD-associated RCC), which has been newly defined by Tickoo et al. (Am J Surg Pathol 30:141–153, 2006).

Ishikawa I. Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002. Nephron Clin Pract. 2004;97:c11–6.CrossRefPubMed

Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology. 1993;22:135–9.CrossRefPubMed

Herts BR, Coll DM, Novick AC, Obuchowski N, Linnell G, Wirth SL, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. Am J Roentgenol. 2002;178:367–72.

Ishikawa I. Acquired cystic disease of the kidney and renal cell carcinoma-complication of long-term hemodialysis. Tokyo: Springer; 2007. p. 1–111.

Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005;29:443–51.CrossRefPubMed

Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141–53.CrossRefPubMed

Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol. 2006;19:780–7.PubMed

Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int. 2010;105:620–7.CrossRefPubMed

Japanese Urological Association, Japanese Society of Pathology, Japanese Radiological Society. General rule for clinical and pathological studies on renal cell carcinoma. 3rd ed. Kanehara Syuppan: Tokyo; 1999.

10.

Ishikawa I. Present status of acquired cystic disease of the kidney (in Japanese). J Jpn Assoc Dial Physicians. 2008;23:179–87.

11.

Ishikawa I. Acquired cysts and cancer of failing kidneys, chap 11. In: Cohen EP, editor. Cancer and the kidney. 2nd ed. Oxford: Oxford University Press; 2010 (in press).

12.

Bosniak MA. Difficulties in classifying cystic lesions of the kidney. Urol Radiol. 1991;13:91–3.CrossRefPubMed

13.

Akiyama T, Onoue A. Sonazoid-enhanced ultrasonography: a diagnosis of kidney and prostate disease (in Japanese). Innervision. 2007;22:41–5.

14.

Ak I, Can C. F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol. 2005;46:895–9.CrossRefPubMed

15.

Ozawa N, Okamura T, Koyama K, Hamazawa Y, Senzaki H, Tanabe S, et al. Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma. Ann Nucl Med. 2007;21:239–43.CrossRefPubMed

Title: Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography
Authors: Isao Ishikawa
Kyoko Morita
Satoshi Hayama
Tetsuya Nakazawa
Ichiro Araki
Kotaro Higashi
Katsuhito Miyazawa
Koji Suzuki
Takayuki Nojima
Publication date: 01-02-2011
Publisher: Springer Japan
Published in: Clinical and Experimental Nephrology / Issue 1/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-010-0347-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Effect of anemia on cardiac disorders in pre-dialysis patients immediately before starting hemodialysis

Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure

Acute peritonitis due to Corynebacterium ulcerans in a patient receiving continuous ambulatory peritoneal dialysis: a case report and literature review

The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts?

Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease

Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page